Evidence map›Paper›PMID 32884131›Full record

ArticleNature immunology2020

Author Correction: Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment.

Xuexian O Yang, Pornpimon Angkasekwinai, Jinfang Zhu, Juan Peng, Zhiduo Liu, Roza Nurieva, Xikui Liu, Yeonseok Chung, Seon Hee Chang, Bing Sun and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xuexian O YangDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA. xoyang@mdanderson.org.
Pornpimon AngkasekwinaiDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
Jinfang ZhuLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Juan PengDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
Zhiduo LiuInstitute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
Roza NurievaDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
Xikui LiuDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
Yeonseok ChungDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
Seon Hee ChangDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
Bing SunInstitute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China. bsun@sibs.ac.cn.
Chen DongDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas, USA. cdong@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32884131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.